RMD

ResMed Inc. NYSE

Healthcare ·Medical - Instruments & Supplies ·US · resmed.com

$205.02

Mkt Cap $30.2B

52w Low $210.60 -6.7% of range 52w High $293.81

50d MA $234.84 200d MA $256.17

P/E (TTM) 21.5x

EV/EBITDA 19.6x

P/B 5.0x

Debt/Equity 0.1x

ROE 22.9%

P/FCF 22.8x

RSI (14) —

ATR (14) —

Beta 0.93

50d MA $234.84

200d MA $256.17

Avg Volume 1.1M

About

ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation de… ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. The company operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME)to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; and HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies. The company markets its products primarily to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force in approximately 140 countries. ResMed Inc. was founded in 1989 and is headquartered in San Diego, California.

Recent Earnings

Date	Time	Est	Rptd	Surp	Base	Gap%	D1%	D2%	D3%	D4%	D5%	1M%	Guide ▲★
Apr 30, 2026	AMC	2.79	2.86	+2.5%	213.81	-3.7%	-4.1%	—	—	—	—	—	—
Jan 29, 2026	AMC	2.74	2.81	+2.6%	257.61	-2.6%	+0.3%	-1.1%	-2.4%	+2.1%	+3.7%	-0.1%	—
Oct 30, 2025	AMC	2.51	2.55	+1.6%	252.26	+0.9%	-2.1%	-1.3%	-2.3%	-2.8%	-1.0%	-1.5%	—
Jul 31, 2025	AMC	2.55	2.55	+0.0%	271.94	+3.7%	+2.7%	+7.2%	+4.8%	+3.1%	+3.0%	-0.3%	—
Apr 23, 2025	AMC	2.38	2.37	-0.4%	214.36	+8.8%	+10.1%	+10.0%	+9.2%	+10.9%	+10.4%	+13.3%	—
Jan 30, 2025	AMC	2.32	2.43	+4.7%	257.65	+0.1%	-8.3%	-6.6%	-6.7%	-5.8%	-7.9%	-9.5%	—
Oct 24, 2024	AMC	2.04	2.20	+7.8%	239.05	+8.8%	+7.1%	+3.3%	+2.2%	+1.7%	+1.4%	+4.4%	—
Aug 1, 2024	AMC	2.07	2.08	+0.5%	214.56	-2.1%	+4.2%	+0.5%	+2.0%	-1.7%	-0.2%	+14.1%	—
Apr 25, 2024	AMC	1.91	2.13	+11.5%	183.42	+10.7%	+18.9%	+18.4%	+16.7%	+17.2%	+18.9%	+12.9%	—
Jan 24, 2024	AMC	1.81	1.88	+3.9%	171.78	+10.4%	+8.5%	+10.7%	+11.3%	+11.4%	+10.7%	+7.1%	—
Oct 26, 2023	AMC	1.62	1.64	+1.2%	138.73	+4.4%	-2.9%	-0.9%	+1.8%	+6.1%	+8.2%	+10.0%	—
Aug 3, 2023	AMC	1.69	1.60	-5.3%	219.95	-9.8%	-18.5%	-15.1%	-18.5%	-19.6%	-19.5%	-30.0%	—

Recent Analyst Ratings

Date	Firm	Action	Grade	Target	Base	Open	Gap%	D1%	D2%	D3%	D4%	D5%
May 1	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$213.81	$206.00	-3.7%	-4.1%	—	—	—	—
May 1	RBC Capital	Maintains	Outperform → Outperform	—	$213.81	$206.00	-3.7%	-4.1%	—	—	—	—
Apr 27	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$219.85	$219.13	-0.3%	+1.0%	-1.2%	-3.6%	-2.7%	-6.7%
Apr 9	Citigroup	Maintains	Buy → Buy	—	$230.70	$227.99	-1.2%	-1.2%	-0.8%	-0.2%	-0.0%	-0.8%
Feb 2	Citigroup	Maintains	Buy → Buy	—	$258.31	$257.18	-0.4%	-1.4%	-2.7%	+1.8%	+3.4%	+5.2%
Jan 30	RBC Capital	Maintains	Outperform → Outperform	—	$257.61	$251.03	-2.6%	+0.3%	-1.1%	-2.4%	+2.1%	+3.7%
Jan 30	Stifel	Maintains	Hold → Hold	—	$257.61	$251.03	-2.6%	+0.3%	-1.1%	-2.4%	+2.1%	+3.7%
Jan 30	Piper Sandler	Maintains	Neutral → Neutral	—	$257.61	$251.03	-2.6%	+0.3%	-1.1%	-2.4%	+2.1%	+3.7%
Jan 30	Wells Fargo	Maintains	Equal Weight → Equal Weight	—	$257.61	$251.03	-2.6%	+0.3%	-1.1%	-2.4%	+2.1%	+3.7%
Dec 18	Stifel	Maintains	Hold → Hold	—	$245.94	$246.10	+0.1%	-1.4%	-0.4%	+0.3%	-0.5%	-0.6%
Dec 16	Baird	Downgrade	Outperform → Neutral	—	$253.07	$248.01	-2.0%	-2.3%	-2.8%	-4.2%	-3.2%	-2.5%
Nov 3	Baird	Maintains	Outperform → Outperform	—	$246.88	$247.54	+0.3%	+0.8%	-0.2%	-0.7%	+1.1%	+1.9%
Oct 31	RBC Capital	Maintains	Outperform → Outperform	—	$252.26	$254.51	+0.9%	-2.1%	-1.3%	-2.3%	-2.8%	-1.0%
Oct 31	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$252.26	$254.51	+0.9%	-2.1%	-1.3%	-2.3%	-2.8%	-1.0%
Oct 31	Mizuho	Maintains	Outperform → Outperform	—	$252.26	$254.51	+0.9%	-2.1%	-1.3%	-2.3%	-2.8%	-1.0%
Oct 21	Morgan Stanley	Maintains	Overweight → Overweight	—	$271.41	$268.02	-1.2%	-1.2%	-1.8%	-2.3%	-4.4%	-4.5%
Aug 1	Mizuho	Maintains	Outperform → Outperform	—	$271.94	$281.90	+3.7%	+2.7%	+7.2%	+4.8%	+3.1%	+3.0%
Aug 1	UBS	Maintains	Buy → Buy	—	$271.94	$281.90	+3.7%	+2.7%	+7.2%	+4.8%	+3.1%	+3.0%
Aug 1	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$271.94	$281.90	+3.7%	+2.7%	+7.2%	+4.8%	+3.1%	+3.0%
Aug 1	Piper Sandler	Maintains	Neutral → Neutral	—	$271.94	$281.90	+3.7%	+2.7%	+7.2%	+4.8%	+3.1%	+3.0%
Aug 1	RBC Capital	Maintains	Outperform → Outperform	—	$271.94	$281.90	+3.7%	+2.7%	+7.2%	+4.8%	+3.1%	+3.0%
Aug 1	Stifel	Maintains	Hold → Hold	—	$271.94	$281.90	+3.7%	+2.7%	+7.2%	+4.8%	+3.1%	+3.0%
Jul 16	Mizuho	Maintains	Outperform → Outperform	—	$252.01	$253.77	+0.7%	+0.9%	+1.7%	+2.3%	+3.6%	+6.1%
Jul 16	RBC Capital	Upgrade	Sector Perform → Outperform	—	$252.01	$253.77	+0.7%	+0.9%	+1.7%	+2.3%	+3.6%	+6.1%
Apr 24	Piper Sandler	Maintains	Neutral → Neutral	—	$214.36	$233.19	+8.8%	+10.1%	+10.0%	+9.2%	+10.9%	+10.4%
Apr 24	UBS	Maintains	Buy → Buy	—	$214.36	$233.19	+8.8%	+10.1%	+10.0%	+9.2%	+10.9%	+10.4%
Apr 24	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$214.36	$233.19	+8.8%	+10.1%	+10.0%	+9.2%	+10.9%	+10.4%
Apr 24	JP Morgan	Maintains	Overweight → Overweight	—	$214.36	$233.19	+8.8%	+10.1%	+10.0%	+9.2%	+10.9%	+10.4%
Apr 24	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$214.36	$233.19	+8.8%	+10.1%	+10.0%	+9.2%	+10.9%	+10.4%
Apr 21	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$212.91	$211.62	-0.6%	-1.0%	+0.5%	+0.7%	+10.9%	+10.8%
Mar 5	Citigroup	Upgrade	Neutral → Buy	—	$231.48	$227.71	-1.6%	-3.3%	-2.8%	+0.4%	+2.2%	-2.5%
Mar 5	Stifel	Maintains	Hold → Hold	—	$231.48	$227.71	-1.6%	-3.3%	-2.8%	+0.4%	+2.2%	-2.5%
Jan 31	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$257.65	$258.00	+0.1%	-8.3%	-6.6%	-6.7%	-5.8%	-7.9%
Jan 31	Piper Sandler	Maintains	Neutral → Neutral	—	$257.65	$258.00	+0.1%	-8.3%	-6.6%	-6.7%	-5.8%	-7.9%
Jan 31	JP Morgan	Maintains	Overweight → Overweight	—	$257.65	$258.00	+0.1%	-8.3%	-6.6%	-6.7%	-5.8%	-7.9%
Jan 31	Needham	Maintains	Hold → Hold	—	$257.65	$258.00	+0.1%	-8.3%	-6.6%	-6.7%	-5.8%	-7.9%
Oct 25	Baird	Maintains	Outperform → Outperform	—	$239.05	$260.00	+8.8%	+7.1%	+3.3%	+2.2%	+1.7%	+1.4%
Oct 25	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$239.05	$260.00	+8.8%	+7.1%	+3.3%	+2.2%	+1.7%	+1.4%
Oct 25	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$239.05	$260.00	+8.8%	+7.1%	+3.3%	+2.2%	+1.7%	+1.4%
Oct 1	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$244.12	$245.37	+0.5%	-2.2%	-2.2%	-2.3%	-4.2%	-4.8%
Sep 26	BofA Securities	Maintains	Buy → Buy	—	$240.75	$245.83	+2.1%	+0.8%	-0.7%	+1.4%	-0.8%	-0.8%
Sep 18	Wolfe Research	Downgrade	Peer Perform → Underperform	—	$250.88	$233.63	-6.9%	-5.1%	-3.1%	-2.4%	-1.9%	-1.5%
Sep 4	Needham	Downgrade	Buy → Hold	—	$244.90	$239.90	-2.0%	-0.1%	-0.0%	-0.0%	+1.9%	+3.3%
Aug 2	Needham	Maintains	Buy → Buy	—	$214.56	$210.00	-2.1%	+4.2%	+0.5%	+2.0%	-1.7%	-0.2%
Aug 2	KeyBanc Capital Markets	Maintains	Overweight → Overweight	—	$214.56	$210.00	-2.1%	+4.2%	+0.5%	+2.0%	-1.7%	-0.2%
Aug 2	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$214.56	$210.00	-2.1%	+4.2%	+0.5%	+2.0%	-1.7%	-0.2%
Jul 23	RBC Capital	Maintains	Sector Perform → Sector Perform	—	$207.28	$207.74	+0.2%	+1.1%	-0.5%	+0.5%	-4.9%	+0.6%
Jun 25	Oppenheimer	Downgrade	Outperform → Perform	—	$182.20	$185.07	+1.6%	+0.9%	+2.4%	+5.1%	+5.1%	+2.6%
Jun 24	Citigroup	Downgrade	Buy → Neutral	—	$205.83	$189.95	-7.7%	-11.5%	-10.7%	-9.4%	-6.9%	-7.0%
Jun 24	Needham	Maintains	Buy → Buy	—	$205.83	$189.95	-7.7%	-11.5%	-10.7%	-9.4%	-6.9%	-7.0%

Recent Filings

8-K

ResMed Inc. -- 8-K Filing

ResMed Inc. announced a shareholder meeting scheduled for May 13-14, 2026, with CFO Brett Sandercock signing disclosure documents regarding corporate governance matters.

Apr 30

Data updated apr 26, 2026 11:08pm · Source: massive.com